David Groff

12PUBLICATIONS
123CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Autonomic nervous systemGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 13, 2026
The PLK4 inhibitor RP-1664 demonstrates potent efficacy in neuroblastoma preclinical models through a dual mechanism of sensitivity.

|Apr 06, 2026
Preclinical Activity of the B7-H3-Targeting Antibody-Drug Conjugate Vobramitamab Duocarmazine in Pediatric Solid Tumors.

Edward Favours, Haiying Tang, Peyton Wong

|Nov 19, 2025
Target antigen-displaying extracellular vesicles boost CAR T cell efficacy in cell and mouse models of neuroblastoma.

Anna Maria Giudice, Stephanie Matlaga, Sydney L Roth

|Nov 07, 2025
Defining the Functional Role and Potential as an Immunotherapeutic Target of ALCAM in Neuroblastoma.

Jarrett Lindsay, Jonathan Gaither, David Groff

|Sep 30, 2025
D3-GPC2-Directed CAR T Cells Are Safe and Efficacious in Preclinical Models of Neuroblastoma and Small Cell Lung Cancer.

Anna Maria Giudice, Stephanie Matlaga, Sydney L Roth

|Aug 14, 2025
A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancers.

Alberto D Guerra, Smita Matkar, Christina Acholla

Pageof 2

Frequent Collaborators

11 joint publications

John Maris

5 joint publications

Yael P Mossé

5 joint publications

Alvin Farrel

4 joint publications

Adam J Wolpaw